CJJD — China Jo-Jo Drugstores Income Statement
0.000.00%
Last trade - 00:00
- $4.81m
- $9.34m
- $148.81m
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 108 | 117 | 133 | 164 | 149 |
Cost of Revenue | |||||
Gross Profit | 25.1 | 25.5 | 29.2 | 36.5 | 34.3 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 108 | 124 | 142 | 167 | 170 |
Operating Profit | -0.876 | -7 | -8.84 | -2.69 | -20.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.18 | -6.44 | -8.34 | -2.1 | -20.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.32 | -6.46 | -8.38 | -3.2 | -21.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.926 | -5.81 | -8.12 | -3.19 | -21.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.926 | -5.81 | -8.12 | -3.19 | -21.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -7.68 | -39.5 | -46.9 | -17.8 | -41.5 |